SCHEMBL22280327

SCHEMBL22280327

CNCCCc1nc(-c2ccc(C(=O)NC)cc2)no1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.59
NPC1 O15118 2/20 0.56
TP53 P04637 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
HDAC4 P56524 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
S1PR2 O95136 1/20 0.52
S1PR1 P21453 1/20 0.52
S1PR3 Q99500 1/20 0.52
LPAR2 Q9HBW0 1/20 0.52
HDAC1 Q13547 6/20 0.51
HDAC2 Q92769 4/20 0.51
HDAC8 Q9BY41 2/20 0.51
ALDH1A1 P00352 1/20 0.50
RAB9A P51151 2/20 0.49
SIRT2 Q8IXJ6 2/20 0.49
LMNA P02545 1/20 0.49
KLF5 Q13887 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26888093 0.87 PLK1 (0.59) PLK1NPC1TP53CYP1A2CYP2C9
SCHEMBL24326619 0.85 S1PR2 (0.49) NPC1TP53CYP1A2CYP2C9CYP2C19
SCHEMBL24326620 0.83 TP53 (0.53) PLK1NPC1TP53CYP1A2CYP2C9
SCHEMBL24326628 0.82 TDP1 (0.64) HDAC1HDAC2HDAC8SIRT2LMNA
SCHEMBL24325677 0.79 S1PR2 (0.53) NPC1TP53CYP1A2CYP2C9CYP2C19
SCHEMBL26691022 0.77 MAPT (0.51) TP53HDAC4HDAC6S1PR2S1PR1
SCHEMBL26690928 0.76 HDAC2 (0.53) NPC1CYP1A2CYP2C9CYP2C19HDAC1
SCHEMBL26690956 0.76 S1PR2 (0.53) HDAC4HDAC6S1PR2S1PR1S1PR3
SCHEMBL22280639 0.76 TP53 (0.49) PLK1NPC1TP53CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL26691018 0.75 S1PR1 (0.64) NPC1S1PR2S1PR1S1PR3LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154431-A1 INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY LYNCH KEVIN R (US) 2020-07-30 WO disclosed